ConductScience.org, home

Paper41550348

Evaluating AI-driven precision oncology for breast cancer in low- and middle-income countries: a review of machine learning performance, genomic data use, and clinical feasibility.

Salazar-Garcés LF and 4 others. Front Digit Health, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Evaluating AI-driven precision oncology for breast cancer in low- and middle-income countries: a review of machine learning performance, genomic data use, and clinical feasibility. Papers, record 41550348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41550348

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluating AI-driven precision oncology for breast cancer in low- and middle-income countries: a review of machine learning performance, genomic data use, and clinical feasibility.
PubMed
Journal
Front Digit Health
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-01-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Salazar-Garcés LFLuis Fabián
2Morales-Urrutia EElizabeth
3Cashabamba FFranklin
4Proaño Alulema RXRicardo Xavier
5Leiva Suero LELizette Elena

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132419014Concordance between treatment recommendations provided by IBM Watson for Oncology and a multidisciplinary tumor board for breast cancer in China.Jpn J Clin Oncol2020https://conductscience.org/library/papers/32419014PubMed
239650663Machine learning based anoikis signature predicts personalized treatment strategy of breast cancer.Front Immunol2024https://conductscience.org/library/papers/39650663PubMed
330849111A clinical decision support system learned from data to personalize treatment recommendations towards preventing breast cancer metastasis.PLoS One2019https://conductscience.org/library/papers/30849111PubMed
439628476Machine learning-informed liquid-liquid phase separation for personalized breast cancer treatment assessment.Front Immunol2024https://conductscience.org/library/papers/39628476PubMed
533538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
640112233Large Language Models as Decision-Making Tools in Oncology: Comparing Artificial Intelligence Suggestions and Expert Recommendations.JCO Clin Cancer Inform2025https://conductscience.org/library/papers/40112233PubMed
732121160Computational Cancer Cell Models to Guide Precision Breast Cancer Medicine.Genes (Basel)2020https://conductscience.org/library/papers/32121160PubMed
827254875Discovery and Clinical Decision Support for Personalized Healthcare.IEEE J Biomed Health Inform2017https://conductscience.org/library/papers/27254875PubMed
939749373Evaluation of machine learning algorithms and computational structural validation of CYP2D6 in predicting the therapeutic response to tamoxifen in breast cancer.Eur Rev Med Pharmacol Sci2024https://conductscience.org/library/papers/39749373PubMed
1039099625Consistency of CSCO AI with Multidisciplinary Clinical Decision-Making Teams in Breast Cancer: A Retrospective Study.Breast Cancer (Dove Med Press)2024https://conductscience.org/library/papers/39099625PubMed
1131419181Artificial Intelligence Treatment Decision Support For Complex Breast Cancer Among Oncologists With Varying Expertise.JCO Clin Cancer Inform2019https://conductscience.org/library/papers/31419181PubMed
1237530243Analysis of Watson for oncology and clinicians' treatment recommendations for patients with breast cancer in Korea: A single center experience.Indian J Cancer2023https://conductscience.org/library/papers/37530243PubMed
1340308601Artificial intelligence-assisted RNA-binding protein signature for prognostic stratification and therapeutic guidance in breast cancer.Front Immunol2025https://conductscience.org/library/papers/40308601PubMed
1439669975Multimodal data fusion AI model uncovers tumor microenvironment immunotyping heterogeneity and enhanced risk stratification of breast cancer.MedComm (2020)2024https://conductscience.org/library/papers/39669975PubMed
1538756785Enhancing breast cancer outcomes with machine learning-driven glutamine metabolic reprogramming signature.Front Immunol2024https://conductscience.org/library/papers/38756785PubMed
1632992569Integrated Multiparametric Radiomics and Informatics System for Characterizing Breast Tumor Characteristics with the OncotypeDX Gene Assay.Cancers (Basel)2020https://conductscience.org/library/papers/32992569PubMed
1728263386Artificial intelligence platform for oncology could assist in treatment decisions.Cancer2017https://conductscience.org/library/papers/28263386PubMed
1829324970Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board.Ann Oncol2018https://conductscience.org/library/papers/29324970PubMed
1932970484Effect of an Artificial Intelligence Clinical Decision Support System on Treatment Decisions for Complex Breast Cancer.JCO Clin Cancer Inform2020https://conductscience.org/library/papers/32970484PubMed
2038504988Integrating PANoptosis insights to enhance breast cancer prognosis and therapeutic decision-making.Front Immunol2024https://conductscience.org/library/papers/38504988PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42752875Sustainable artificial intelligence in global health: balancing promise, equity, and environmental realities in low- and middle-income countries.J Am Med Inform Assoc2026https://conductscience.org/library/papers/42752875PubMed
42589412Artificial Intelligence and Genomic Data Analysis: New Frontiers in Precision Medicine.Int J Mol Sci2026https://conductscience.org/library/papers/42589412PubMed
42072806Advances in Breast Cancer Diagnostics: From Screening to Precision Medicine.Diagnostics (Basel)2026https://conductscience.org/library/papers/42072806PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41550348

GET https://conductscience.org/api/papers/v1/41550348/authors